← Leaderboards
Deanna E. Cheek
Medical University Of South Carolina
$1,939,857
Attributed
$1,939,857
Total exposure
6
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $246.8K · FY2005–08$250K$187.5K$125K$62.5K$0
'05
'06
'07
'08
Funding mix
By agency
NIH$1,939,857 · 6
By mechanism
U01$1,675,748 · 1
M01$264,109 · 5
Top collaborators
No co-investigators on record.
Most similar at Medical University Of South Carolina
Same institution · by research overlap
- Maria F Lopes-Virella$3,980,090
- Timothy J Lyons$5,303,277
- Ayad A Jaffa$7,063,873
- Yan Huang$5,705,032
- William Scott Argraves$10,691,634
Others in their field
Top investigators on “Antihypertensive Agents”
- Oscar R Benavente · University Of Texas Hlth Sci Ctr San Ant$23,027,330
- Garret A Fitzgerald · University Of Pennsylvania$20,602,198
- Adnan Iqbal Qureshi · Univ Of Med/Dent Of Nj-Nj Medical School$18,880,151
- Alan Thevenet N. Tita · University Of Alabama At Birmingham$18,623,876
- Eric B Larson · University Of Washington$12,917,655
- Betty Diamond · Feinstein Institute For Medical Research$12,509,886
Research focus
Antihypertensive AgentsAfrican AmericanBlood PressureHuman SubjectChronic Renal FailureRenal HypertensionHuman Therapy EvaluationCardiovascular Disorder ChemotherapyClinical ResearchGlomerular Filtration RateClinical TrialsRacial /Ethnic DifferencePathologic ProcessProteinuriaCooperative StudyKidney Disorder ChemotherapyCardiovascular Disorder EpidemiologyKidney Disorder DiagnosisAce InhibitorsResourcesCreatinineCalcium Channel BlockersEnd Stage Renal FailureDisease /Disorder Proneness /Risk
Grant awards (17)
THE AASK AMBULATORY BP PILOT STUDY: THE EFFECTS OF RAMIPRIL ON NOCTURNAL BP$41,463
M01 · FY2008 · RR · contact PI
CLINICAL TRIAL: AASK COHORT STUDY$19,762
M01 · FY2008 · RR · contact PI
AASK COHORT STUDY$92,006
M01 · FY2007 · RR · contact PI
AASK Cohort Study$54,723
U01 · FY2007 · DK · contact PI
AASK Cohort Study$132,726
U01 · FY2006 · DK · contact PI
AASK Cohort Study$135,920
U01 · FY2005 · DK
AASK COHORT STUDY$110,878
M01 · FY2005 · RR
AASK Cohort Study$135,920
U01 · FY2004 · DK
AASK Cohort Study$135,920
U01 · FY2003 · DK
CHARLESTON STUDY OF KIDNEY DISEASE IN AFRICAN AMERICANS$168,614
U01 · FY2002 · DK
AFRICAN AMERICAN STUDY OF KIDNEY DISEASE$0
M01 · FY2002 · RR
CHARLESTON STUDY OF KIDNEY DISEASE IN AFRICAN AMERICANS$473,882
U01 · FY2001 · DK
AFRICAN AMERICAN STUDY OF KIDNEY DISEASE$0
M01 · FY2001 · RR
AFRICAN AMERICAN STUDY OF KIDNEY DISEASE$0
M01 · FY2001 · RR
AFRICAN AMERICAN STUDY OF KIDNEY DISEASE$0
M01 · FY2001 · RR
CHARLESTON STUDY OF KIDNEY DISEASE IN AFRICAN AMERICANS$438,043
U01 · FY2000 · DK
AFRICAN AMERICAN STUDY OF KIDNEY DISEASE$0
M01 · FY2000 · RR